Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Apr 15;97(8):1978–1982. doi: 10.1172/JCI118630

The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3', 5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats.

H M Siragy 1, R M Carey 1
PMCID: PMC507268  PMID: 8621783

Abstract

The renal effects of angiotensin II(AII) are attributed to AT1 receptors. In contrast, the function of renal AT2 receptors in unknown. Using a microdialysis technique, we monitored changes in renal interstitial fluid (RIF) prostaglandin E2 (PGE2) and cyclic guanosine 3', 5'-monophosphate (cGMP) in response to dietary sodium (Na) depletion alone, or Na depletion or normal Na diet combined with the AT1 receptor blocker, Losartan, the AT2 receptor blocker, PD 123319 (PD), or angiotensin II, individually or combined in conscious rats. Na depletion significantly increased PGE2 and cGMP. During Na depletion, Losartan decreased PGE2 and did not change cGMP. In contrast, PD significantly increased PGE2 and decreased cGMP. Combined administration of Losartan and PD decreased PGE2 and cGMP. During normal Na diet, RIF PGE2 and cGMP increased in response to angiotensin II. Neither Losartan nor PD, individually or combined, changed RIF PGE2 or cGMP. Combined administration of angiotensin II and Losartan or PD produced a significant decrease in response of PGE2 and cGMP to angiotensin II, respectively. These data demonstrate that activation of the reninangiotensin system during Na depletion increases renal interstitial PGE2 and cGMP. The AT1 receptor mediates renal production of PGE2. The AT2 receptor mediates cGMP. AT2 blockade potentiates angiotensin-induced PGE2 production at the AT1 receptor.

Full Text

The Full Text of this article is available as a PDF (156.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chevalier R. L., Fern R. J., Garmey M., el-Dahr S. S., Gomez R. A., De Vente J. Localization of cGMP after infusion of ANP or nitroprusside in the maturing rat. Am J Physiol. 1992 Mar;262(3 Pt 2):F417–F424. doi: 10.1152/ajprenal.1992.262.3.F417. [DOI] [PubMed] [Google Scholar]
  2. Clark K. L., Robertson M. J., Drew G. M. Role of angiotensin AT1 and AT2 receptors in mediating the renal effects of angiotensin II in the anaesthetized dog. Br J Pharmacol. 1993 May;109(1):148–156. doi: 10.1111/j.1476-5381.1993.tb13545.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dudley D. T., Panek R. L., Major T. C., Lu G. H., Bruns R. F., Klinkefus B. A., Hodges J. C., Weishaar R. E. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol. 1990 Sep;38(3):370–377. [PubMed] [Google Scholar]
  4. Ernsberger P., Zhou J., Damon T. H., Douglas J. G. Angiotensin II receptor subtypes in cultured rat renal mesangial cells. Am J Physiol. 1992 Sep;263(3 Pt 2):F411–F416. doi: 10.1152/ajprenal.1992.263.3.F411. [DOI] [PubMed] [Google Scholar]
  5. Harper J. F., Brooker G. Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2'0 acetylation by acetic anhydride in aqueous solution. J Cyclic Nucleotide Res. 1975;1(4):207–218. [PubMed] [Google Scholar]
  6. Hopkins N. K., Gorman R. R. Regulation of endothelial cell cyclic nucleotide metabolism by prostacyclin. J Clin Invest. 1981 Feb;67(2):540–546. doi: 10.1172/JCI110064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Johnson M. D., Malvin R. L. Plasma renin activity during pentobarbital anesthesia and graded hemorrhage in dogs. Am J Physiol. 1975 Oct;229(4):1098–1101. doi: 10.1152/ajplegacy.1975.229.4.1098. [DOI] [PubMed] [Google Scholar]
  8. Keiser J. A., Bjork F. A., Hodges J. C., Taylor D. G., Jr Renal hemodynamic and excretory responses to PD 123319 and losartan, nonpeptide AT1 and AT2 subtype-specific angiotensin II ligands. J Pharmacol Exp Ther. 1992 Sep;262(3):1154–1160. [PubMed] [Google Scholar]
  9. Lim L. K., Hunt N. H., Eichner R. D., Weidemann M. J. Cyclic AMP and the regulation of prostaglandin production by macrophages. Biochem Biophys Res Commun. 1983 Jul 18;114(1):248–254. doi: 10.1016/0006-291x(83)91620-0. [DOI] [PubMed] [Google Scholar]
  10. Lo M., Liu K. L., Lantelme P., Sassard J. Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats. J Clin Invest. 1995 Mar;95(3):1394–1397. doi: 10.1172/JCI117792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Macari D., Bottari S., Whitebread S., De Gasparo M., Levens N. Renal actions of the selective angiotensin AT2 receptor ligands CGP 42112B and PD 123319 in the sodium-depleted rat. Eur J Pharmacol. 1993 Nov 2;249(1):85–93. doi: 10.1016/0014-2999(93)90665-5. [DOI] [PubMed] [Google Scholar]
  12. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  13. Navar L. G., Rosivall L. Contribution of the renin-angiotensin system to the control of intrarenal hemodynamics. Kidney Int. 1984 Jun;25(6):857–868. doi: 10.1038/ki.1984.102. [DOI] [PubMed] [Google Scholar]
  14. Powell W. S. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins. 1980 Nov;20(5):947–957. doi: 10.1016/0090-6980(80)90144-6. [DOI] [PubMed] [Google Scholar]
  15. Salvemini D., Seibert K., Masferrer J. L., Misko T. P., Currie M. G., Needleman P. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation. J Clin Invest. 1994 May;93(5):1940–1947. doi: 10.1172/JCI117185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Siragy H. M., Howell N. L., Ragsdale N. V., Carey R. M. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension. 1995 May;25(5):1021–1024. doi: 10.1161/01.hyp.25.5.1021. [DOI] [PubMed] [Google Scholar]
  17. Siragy H. M., Ibrahim M. M., Jaffa A. A., Mayfield R., Margolius H. S. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake. Hypertension. 1994 Jun;23(6 Pt 2):1068–1070. doi: 10.1161/01.hyp.23.6.1068. [DOI] [PubMed] [Google Scholar]
  18. Siragy H. M., Jaffa A. A., Margolius H. S. Stimulation of renal interstitial bradykinin by sodium depletion. Am J Hypertens. 1993 Oct;6(10):863–866. doi: 10.1093/ajh/6.10.863. [DOI] [PubMed] [Google Scholar]
  19. Sonnenburg W. K., Beavo J. A. Cyclic GMP and regulation of cyclic nucleotide hydrolysis. Adv Pharmacol. 1994;26:87–114. doi: 10.1016/s1054-3589(08)60052-6. [DOI] [PubMed] [Google Scholar]
  20. Wong P. Y., Terragno D. A., Terragno N. A., McGiff J. C. Dual effects of bradykinin on prostaglandin metabolism: relationship to the dissimilar vascular actions of kinins. Prostaglandins. 1977 Jun;13(6):1113–1125. doi: 10.1016/0090-6980(77)90138-1. [DOI] [PubMed] [Google Scholar]
  21. Zhuo J., Alcorn D., Harris P. J., Mendelsohn F. A. Localization and properties of angiotensin II receptors in rat kidney. Kidney Int Suppl. 1993 Jul;42:S40–S46. [PubMed] [Google Scholar]
  22. Zhuo J., Song K., Harris P. J., Mendelsohn F. A. In vitro autoradiography reveals predominantly AT1 angiotensin II receptors in rat kidney. Ren Physiol Biochem. 1992 Sep-Oct;15(5):231–239. doi: 10.1159/000173458. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES